期刊： EUROPEAN JOURNAL OF CANCER, 2021; 148 ()
Background: Complete remission is observed in less than half of hypermutated (HM) tumours after immune checkpoint blockade therapy, indicating that HM......
期刊： EUROPEAN JOURNAL OF CANCER, 2021; 151 ()
Aim: This study aimed to identify the functional genes and genetic variants associated with the prognosis of pancreatic ductal adenocarcinoma (PDAC) a......
期刊： EUROPEAN JOURNAL OF CANCER, 2021; 148 ()
Background: GLS-010, a novel engineered fully human immunoglobin G4 monoclonal antibody, can specially block the PD-1/PD-L1/2 axis and reactivate the ......
期刊： EUROPEAN JOURNAL OF CANCER, 2021; 151 ()
Background: To investigate the value of post-induction chemotherapy (IC) cell-free Epstein-Barr virus DNA (cfEBV DNApostIC) for prognostication in loc......
期刊： EUROPEAN JOURNAL OF CANCER, 2021; 150 ()
Objective: Leptomeningeal metastases (LM) occur in up to 5% of non-small cell lung cancer (NSCLC) patients and often develop after previous systemic t......
期刊： EUROPEAN JOURNAL OF CANCER, 2021; 148 ()
Background: Genetic aberrations in the cyclin-dependent kinase (CDK)4 pathway occur in 82% of patients with acral melanoma (AM), which is the predomin......
期刊： EUROPEAN JOURNAL OF CANCER, 2021; 155 ()
Aim: The prediction model of postoperative survival for single large and huge hepatocellular carcinoma (SLH-HCC, diameter > 5.0 cm) without portal ......
期刊： EUROPEAN JOURNAL OF CANCER, 2021; 154 ()
Purpose: We investigate the prognostic value of tumour-infiltrating lymphocytes (TILs) based on the evaluation of the present frequency in patients wi......
期刊： EUROPEAN JOURNAL OF CANCER, 2021; 155 ()
Aim: The aim of this study is to develop and test radiomics models based on magnetic resonance imaging (MRI) to preoperatively and respectively predic......
